logo
v4.0
登录 注册
商品名
活性成分
中文名称
申请类型
申请号
剂型
申请机构
批准日期
Lisdexamfetamine Dimesylate
二甲磺酸赖右苯丙胺
ANDA
219258
Tablet, Chewable;Oral
Granules
2024-12-16
Drospirenone
屈螺酮
ANDA
216936
Tablet;Oral
Lupin Ltd
2024-12-13
Emtricitabine; Tenofovir Alafenamide Fumarate
恩曲他滨;富马酸丙酚替诺福韦
ANDA
213926
Tablet;Oral
Lupin Ltd
2024-12-13
Loteprednol Etabonate
氯替泼诺
ANDA
216345
Suspension/drops;Ophthalmic
Amneal
2024-12-13
Furosemide
呋塞米
ANDA
217557
Injectable;Injection
Aspiro
2024-12-13
Crinecerfont
可瑞舍封
NDA
218808
Capsule;Oral
Neurocrine
2024-12-13
Crinecerfont
可瑞舍封
NDA
218820
Solution;Oral
Neurocrine
2024-12-13
Lactulose
乳果糖
ANDA
218858
Solution;Oral
Taro
2024-12-13
Difluprednate
二氟泼尼酯
ANDA
219441
Emulsion;Ophthalmic
Caplin
2024-12-13
Cosibelimab-ipdl
BLA
761297
Injectable;Injection
Checkpoint Therapeutics Inc
2024-12-13
Nemolizumab-ilto
奈莫利组单抗
BLA
761391
Injectable;Injection
Galderma Labs Lp
2024-12-13
Glucagon
高血糖素
ANDA
204468
Injectable;Injection
Mylan Labs Ltd
2024-12-12
Clozapine
氯氮平
ANDA
212923
Tablet, Orally Disintegrating;Oral
Aurobindo Pharma
2024-12-12
Aprepitant
阿瑞匹坦
ANDA
216976
Injection, Emulsion
Mylan Pharmaceuticals Inc
2024-12-11
Solriamfetol
索安非托
ANDA
218654
Tablet
Hetero Labs Limited
2024-12-11
Sitagliptin, Metformin Hydrochloride
ANDA
218971
Tablet
Mankind Pharma Ltd
2024-12-11
Nilotinib Hydrochloride Dihydrate
ANDA
209651
Capsule
Hetero Labs Limited
2024-12-10
Bexarotene
贝沙罗汀
ANDA
210352
Capsule;Oral
Cipla
2024-12-10
Ezetimibe; Simvastatin
依折麦布;辛伐他汀
ANDA
211663
Tablet;Oral
Sciegen Pharms Inc
2024-12-10
Eliglustat Tartrate
酒石酸艾格司他胶囊
ANDA
212369
Capsule;Oral
Cipla
2024-12-10
%s %s
共 27532 条 上一页 1 2345 10 下一页 到第 查看50页数据
客服热线
177-5492-8956
xry@wuxuwang.com
美国上市药品数据库提供了在美国上市或曾经上市的全部药品的详细信息查询.
友情链接: